Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 295

1.

Acute myeloid leukaemia (FAB AML-M4Eo) with cryptic insertion of cbfb resulting in cbfb-Myh11 fusion.

Douet-Guilbert N, Chauveau A, Gueganic N, Guillerm G, Tous C, Le Bris MJ, Basinko A, Morel F, Ugo V, De Braekeleer M.

Hematol Oncol. 2017 Sep;35(3):385-389. doi: 10.1002/hon.2268. Epub 2015 Nov 2. Review.

PMID:
28906004
2.

The MLL recombinome of acute leukemias in 2017.

Meyer C, Burmeister T, Gröger D, Tsaur G, Fechina L, Renneville A, Sutton R, Venn NC, Emerenciano M, Pombo-de-Oliveira MS, Barbieri Blunck C, Almeida Lopes B, Zuna J, Trka J, Ballerini P, Lapillonne H, De Braekeleer M, Cazzaniga G, Corral Abascal L, van der Velden VHJ, Delabesse E, Park TS, Oh SH, Silva MLM, Lund-Aho T, Juvonen V, Moore AS, Heidenreich O, Vormoor J, Zerkalenkova E, Olshanskaya Y, Bueno C, Menendez P, Teigler-Schlegel A, Zur Stadt U, Lentes J, Göhring G, Kustanovich A, Aleinikova O, Schäfer BW, Kubetzko S, Madsen HO, Gruhn B, Duarte X, Gameiro P, Lippert E, Bidet A, Cayuela JM, Clappier E, Alonso CN, Zwaan CM, van den Heuvel-Eibrink MM, Izraeli S, Trakhtenbrot L, Archer P, Hancock J, Möricke A, Alten J, Schrappe M, Stanulla M, Strehl S, Attarbaschi A, Dworzak M, Haas OA, Panzer-Grümayer R, Sedék L, Szczepański T, Caye A, Suarez L, Cavé H, Marschalek R.

Leukemia. 2018 Feb;32(2):273-284. doi: 10.1038/leu.2017.213. Epub 2017 Jul 13.

3.

Asbestos-related lung cancers: A retrospective clinical and pathological study.

Uguen M, Dewitte JD, Marcorelles P, Loddé B, Pougnet R, Saliou P, De Braekeleer M, Uguen A.

Mol Clin Oncol. 2017 Jul;7(1):135-139. doi: 10.3892/mco.2017.1277. Epub 2017 May 30.

4.

Sperm RNA preparation for transcriptomic analysis: Review of the techniques and personal experience.

El Fekih S, Nguyen MH, Perrin A, Beauvillard D, Morel F, Saad A, Ben Ali H, De Braekeleer M.

Andrologia. 2017 Dec;49(10). doi: 10.1111/and.12767. Epub 2017 Mar 6. Review.

PMID:
28261842
5.

Fluorescence in situ hybridization testing of chromosomes 6, 8, 9 and 11 in melanocytic tumors is difficult to automate and reveals tumor heterogeneity in melanomas.

Uguen A, Uguen M, Talagas M, Gobin E, Marcorelles P, De Braekeleer M.

Oncol Lett. 2016 Oct;12(4):2734-2741. Epub 2016 Aug 3.

6.

The p16-Ki-67-HMB45 Immunohistochemistry Scoring System is Highly Concordant With the Fluorescent In Situ Hybridization Test to Differentiate Between Melanocytic Nevi and Melanomas.

Uguen A, Uguen M, Guibourg B, Talagas M, Marcorelles P, De Braekeleer M.

Appl Immunohistochem Mol Morphol. 2018 Jul;26(6):361-367. doi: 10.1097/PAI.0000000000000428.

PMID:
27490764
7.

ALK ambiguous-positive non-small cell lung cancers are tumors challenged by diagnostic and therapeutic issues.

Uguen A, Andrieu-Key S, Vergne F, Descourt R, Quéré G, Quintin-Roué I, Key S, Guéguen P, Talagas M, De Braekeleer M, Marcorelles P.

Oncol Rep. 2016 Sep;36(3):1427-34. doi: 10.3892/or.2016.4962. Epub 2016 Jul 21.

PMID:
27460205
8.

Prognostic impact of p15 gene aberrations in acute leukemia.

De Braekeleer M, Douet-Guilbert N, De Braekeleer E.

Leuk Lymphoma. 2017 Feb;58(2):257-265. Epub 2016 Jul 12. Review.

PMID:
27401303
9.

ROS1 fusions in cancer: a review.

Uguen A, De Braekeleer M.

Future Oncol. 2016 Aug;12(16):1911-28. doi: 10.2217/fon-2016-0050. Epub 2016 Jun 3. Review.

PMID:
27256160
10.

Is SP174 Immunohistochemistry an Interesting Ancillary Tool to Determine RAS Mutational Status in Colorectal Carcinoma?

Uguen A, Gueguen P, Guibourg B, Duigou S, Pochic M, Conq G, Samaison L, Marcorelles P, De Braekeleer M.

Appl Immunohistochem Mol Morphol. 2017 Mar;25(3):e25-e26. doi: 10.1097/PAI.0000000000000375. No abstract available.

PMID:
27153446
11.

Immunoglobulin gene translocations in chronic lymphocytic leukemia: A report of 35 patients and review of the literature.

DE Braekeleer M, Tous C, Guéganic N, LE Bris MJ, Basinko A, Morel F, Douet-Guilbert N.

Mol Clin Oncol. 2016 May;4(5):682-694. Epub 2016 Feb 26.

12.

NRASQ61R and BRAFV600E Mutation-specific Immunohistochemistry Is a Helpful Tool to Diagnose Metastatic Undifferentiated/Dedifferentiated Melanomas.

Uguen A, Sassolas B, Mondine P, Doucet L, Ginestet F, Benigni P, Costa S, De Braekeleer M, Marcorelles P.

Am J Surg Pathol. 2016 Jul;40(7):1004-5. doi: 10.1097/PAS.0000000000000647. No abstract available.

PMID:
26999502
13.

False ALK Rearrangement Signals in Inflammatory Cells: A Pitfall in the Interpretation of ALK Fluorescence In Situ Hybridization in Non-Small Cell Lung Cancer.

Uguen A, Talagas M, Andrieu-Key S, Quintin-Roué I, Marcorelles P, De Braekeleer M.

Appl Immunohistochem Mol Morphol. 2017 Oct;25(9):668-670. doi: 10.1097/PAI.0000000000000351.

PMID:
26945447
14.

Challenges in ovarian stimulation.

Merviel P, LE Martelot MT, Roche S, Lelièvre C, Menard M, Auget S, Beauvillard D, Amice V, De Braekeleer M.

Minerva Ginecol. 2016 Dec;68(6):625-41. Epub 2016 Mar 1. Review.

PMID:
26930391
15.

BRAFV600E and NRASQ61R Homogeneity in Melanoma Tumors.

Uguen A, Talagas M, Marcorelles P, De Braekeleer M.

J Invest Dermatol. 2016 Jan;136(1):337-8. doi: 10.1038/JID.2015.348. No abstract available.

16.

Targeting BRAF mutants in clear-cell sarcomas of soft tissue: beyond sarcoma or melanoma classification.

Uguen A, Marcorelles P, De Braekeleer M.

Invest New Drugs. 2016 Apr;34(2):253-4. doi: 10.1007/s10637-015-0319-2. Epub 2016 Jan 8. No abstract available.

PMID:
26746214
17.

NRASQ61R immunohistochemistry: a new tool for mutational status screening in challenging melanoma samples.

Uguen A, Talagas M, Costa S, De Braekeleer M, Marcorelles P.

Mod Pathol. 2016 Jan;29(1):91-2. doi: 10.1038/modpathol.2015.78. No abstract available.

18.

ALK-rearranged squamous cell lung carcinoma responding to crizotinib: A missing link in the field of non-small cell lung cancer?

Vergne F, Quéré G, Andrieu-Key S, Descourt R, Quintin-Roué I, Talagas M, De Braekeleer M, Marcorelles P, Uguen A.

Lung Cancer. 2016 Jan;91:67-9. doi: 10.1016/j.lungcan.2015.11.010. Epub 2015 Nov 10.

PMID:
26603857
19.

A Place for BRAFV600E Mutation-specific Immunohistochemistry Alongside Cell-free DNA Mutation Detection in Melanoma.

Uguen A, Talagas M, De Braekeleer M, Marcorelles P.

Acta Derm Venereol. 2016 Mar;96(3):426-7. doi: 10.2340/00015555-2286. No abstract available.

20.

A p16-Ki-67-HMB45 immunohistochemistry scoring system as an ancillary diagnostic tool in the diagnosis of melanoma.

Uguen A, Talagas M, Costa S, Duigou S, Bouvier S, De Braekeleer M, Marcorelles P.

Diagn Pathol. 2015 Oct 26;10:195. doi: 10.1186/s13000-015-0431-9.

21.

BRAFV600E and NRASQ61R Homogeneity in Melanoma Tumors.

Uguen A, Talagas M, Marcorelles P, De Braekeleer M.

J Invest Dermatol. 2015 Sep 3. doi: 10.1038/jid.2015.348. [Epub ahead of print] No abstract available.

PMID:
26334324
22.

BRAF and NRAS Mutations are Not Mutually Exclusive in Melanoma and in Single Melanoma Cells.

Uguen A, Guéguen P, Talagas M, Costa S, De Braekeleer M, Marcorelles P.

Appl Immunohistochem Mol Morphol. 2016 Mar;24(3):e14-5. doi: 10.1097/PAI.0000000000000217. No abstract available.

PMID:
26317309
23.

Dual NRASQ61R and BRAFV600E mutation-specific immunohistochemistry completes molecular screening in melanoma samples in a routine practice.

Uguen A, Guéguen P, Legoupil D, Bouvier S, Costa S, Duigou S, Lemasson G, Ledé F, Sassolas B, Talagas M, Férec C, Le Maréchal C, De Braekeleer M, Marcorelles P.

Hum Pathol. 2015 Nov;46(11):1582-91. doi: 10.1016/j.humpath.2015.06.023. Epub 2015 Jul 15.

PMID:
26297254
24.

Geographic/ethnic variability of chromosomal and molecular abnormalities in leukemia.

De Braekeleer M, De Braekeleer E, Douet-Guilbert N.

Expert Rev Anticancer Ther. 2015;15(9):1093-102. doi: 10.1586/14737140.2015.1068123. Epub 2015 Jul 27. Review.

PMID:
26211807
25.

BCR-ABL1 b3a2 and b2a2 transcripts in chronic myeloid leukemia: does it matter?

De Braekeleer M.

Eur J Haematol. 2016 Apr;96(4):329-30. doi: 10.1111/ejh.12639. No abstract available.

PMID:
26208040
26.

NRAS (Q61R), BRAF (V600E) immunohistochemistry: a concomitant tool for mutation screening in melanomas.

Uguen A, Talagas M, Costa S, Samaison L, Paule L, Alavi Z, De Braekeleer M, Le Marechal C, Marcorelles P.

Diagn Pathol. 2015 Jul 25;10:121. doi: 10.1186/s13000-015-0359-0.

27.

Searching for ROS1 Rearrangements in Lung Cancer by Fluorescent In Situ Hybridization: The Importance of Probe Design.

Uguen A, Marcorelles P, De Braekeleer M.

J Thorac Oncol. 2015 Aug;10(8):e83-5. doi: 10.1097/JTO.0000000000000605. No abstract available.

28.

Next-Generation Sequencing and Immunohistochemistry as Future Gold Standard of ALK Testing in Lung Cancer?

Uguen A, Talagas M, Marcorelles P, Guéguen P, Costa S, Andrieu-Key S, De Braekeleer M.

Oncologist. 2015 Aug;20(8):e24. doi: 10.1634/theoncologist.2015-0123. Epub 2015 Jul 8. No abstract available.

29.

3q26/EVI1 rearrangements in myeloid hemopathies: a cytogenetic review.

De Braekeleer M, Le Bris MJ, De Braekeleer E, Basinko A, Morel F, Douet-Guilbert N.

Future Oncol. 2015;11(11):1675-86. doi: 10.2217/fon.15.64. Review.

PMID:
26043219
30.

Translocations involving 13q14 without associated deletion in chronic lymphoid leukaemia target DLEU2.

De Braekeleer M, Guéganic N, Tous C, Le Bris MJ, Basinko A, Morel F, Douet-Guilbert N.

Br J Haematol. 2016 Feb;172(3):467-9. doi: 10.1111/bjh.13495. Epub 2015 May 11. No abstract available.

PMID:
25960054
31.

Jumping translocation involving 13q34 in chronic lymphocytic leukemia: report of the first case studied by fluorescent in situ hybridization.

De Braekeleer M, Guéganic N, Tous C, Le Bris MJ, Basinko A, Morel F, Douet-Guilbert N.

Leuk Lymphoma. 2016;57(1):223-5. doi: 10.3109/10428194.2015.1045902. No abstract available.

PMID:
25926065
32.

ALK FISH rearranged and amplified tumor with negative immunohistochemistry: a rare and challenging case concerning ALK status screening in lung cancer.

Uguen A, Talagas M, Andrieu-Key S, Costa S, Quintin-Roué I, De Braekeleer M, Marcorelles P.

Ann Oncol. 2015 Jul;26(7):1514-5. doi: 10.1093/annonc/mdv210. Epub 2015 Apr 28. No abstract available.

PMID:
25922061
33.

Duplication of SOX3 (Xq27) may be a risk factor for Neural Tube Defects.

Uguen A, Talagas M, Quémener-Redon S, Marcorelles P, De Braekeleer M.

Am J Med Genet A. 2015 Jul;167(7):1676-8. doi: 10.1002/ajmg.a.37072. Epub 2015 Apr 21. No abstract available.

PMID:
25900196
34.

[Congenital bilateral absence of vas deferens: From diagnosis to assisted reproductive techniques - the experience of three centers].

Beauvillard D, Perrin A, Drapier H, Ravel C, Fréour T, Férec C, De Braekeleer M, Amice V.

Gynecol Obstet Fertil. 2015 May;43(5):367-74. doi: 10.1016/j.gyobfe.2015.03.009. Epub 2015 Apr 17. French.

PMID:
25899114
35.

Immunostaining of phospho-histone H3 and Ki-67 improves reproducibility of recurrence risk assessment of gastrointestinal stromal tumors.

Uguen A, Conq G, Doucet L, Talagas M, Costa S, De Braekeleer M, Marcorelles P.

Virchows Arch. 2015 Jul;467(1):47-54. doi: 10.1007/s00428-015-1763-2. Epub 2015 Apr 1.

PMID:
25823616
36.

Genetic aspects of monomorphic teratozoospermia: a review.

De Braekeleer M, Nguyen MH, Morel F, Perrin A.

J Assist Reprod Genet. 2015 Apr;32(4):615-23. doi: 10.1007/s10815-015-0433-2. Epub 2015 Feb 25. Review.

37.

A study of aneuploidy and DNA fragmentation in spermatozoa of three men with sex chromosome mosaicism including a 45,X cell line.

Nguyen MH, Morel F, Bujan L, May-Panloup P, De Braekeleer M, Perrin A.

Hum Fertil (Camb). 2015 Jun;18(2):96-9. doi: 10.3109/14647273.2014.988663. Epub 2014 Dec 29.

PMID:
25545806
38.

Breakpoint heterogeneity in (2;3)(p15-23;q26) translocations involving EVI1 in myeloid hemopathies.

De Braekeleer M, Guéganic N, Tous C, Le Bris MJ, Basinko A, Morel F, Douet-Guilbert N.

Blood Cells Mol Dis. 2015 Feb;54(2):160-3. doi: 10.1016/j.bcmd.2014.11.015. Epub 2014 Nov 26.

PMID:
25486926
39.

MLL partner genes in secondary acute lymphoblastic leukemia: report of a new partner PRRC1 and review of the literature.

Douet-Guilbert N, Eveillard JR, Meyer C, Ugo V, Le Bris MJ, Basinko A, Morel F, Marschalek R, De Braekeleer M.

Leuk Res. 2014 Nov;38(11):1316-9. doi: 10.1016/j.leukres.2014.08.011. Epub 2014 Aug 29. Review.

PMID:
25205603
40.

A novel translocation (6;20)(q13;q12) in acute myeloid leukemia likely results in LMBRD1-CHD6 fusion.

Douet-Guilbert N, De Braekeleer E, Tous C, Guéganic N, Basinko A, Le Bris MJ, Morel F, De Braekeleer M.

Leuk Lymphoma. 2015 Feb;56(2):527-8. doi: 10.3109/10428194.2014.924122. Epub 2014 Jul 15. No abstract available.

PMID:
24844365
41.

Translocation t(2;7)(p11;q21) associated with the CDK6/IGK rearrangement is a rare but recurrent abnormality in B-cell lymphoproliferative malignancies.

Douet-Guilbert N, Tous C, Le Flahec G, Bovo C, Le Bris MJ, Basinko A, Morel F, De Braekeleer M.

Cancer Genet. 2014 Mar;207(3):83-6. doi: 10.1016/j.cancergen.2014.02.009. Epub 2014 Feb 28.

PMID:
24726269
42.

RARA fusion genes in acute promyelocytic leukemia: a review.

De Braekeleer E, Douet-Guilbert N, De Braekeleer M.

Expert Rev Hematol. 2014 Jun;7(3):347-57. doi: 10.1586/17474086.2014.903794. Epub 2014 Apr 10. Review.

PMID:
24720386
43.

Balanced complex chromosome rearrangement in male infertility: case report and literature review.

Nguyen MH, Morel F, Pennamen P, Parent P, Douet-Guilbert N, Le Bris MJ, Basinko A, Roche S, De Braekeleer M, Perrin A.

Andrologia. 2015 Mar;47(2):178-85. doi: 10.1111/and.12245. Epub 2014 Feb 24. Review.

PMID:
24612408
44.

Hox gene dysregulation in acute myeloid leukemia.

De Braekeleer E, Douet-Guilbert N, Basinko A, Le Bris MJ, Morel F, De Braekeleer M.

Future Oncol. 2014 Feb;10(3):475-95. doi: 10.2217/fon.13.195. Review.

PMID:
24559452
45.

Genetic diagnosis in malignant hemopathies: from cytogenetics to next-generation sequencing.

De Braekeleer E, Douet-Guilbert N, De Braekeleer M.

Expert Rev Mol Diagn. 2014 Mar;14(2):127-9. doi: 10.1586/14737159.2014.872563. Epub 2014 Jan 20.

PMID:
24437978
46.

Breast implant-associated anaplastic large-cell lymphoma can be a diagnostic challenge for pathologists.

Talagas M, Uguen A, Charles-Petillon F, Conan-Charlet V, Marion V, Hu W, Amice J, De Braekeleer M.

Acta Cytol. 2014;58(1):103-7. doi: 10.1159/000355861. Epub 2013 Nov 19.

PMID:
24281566
47.

Recurrent translocation (10;17)(p15;q21) in acute poorly differentiated myeloid leukemia likely results in ZMYND11-MBTD1 fusion.

De Braekeleer E, Auffret R, Douet-Guilbert N, Basinko A, Le Bris MJ, Morel F, De Braekeleer M.

Leuk Lymphoma. 2014 May;55(5):1189-90. doi: 10.3109/10428194.2013.820292. Epub 2013 Aug 5. No abstract available.

PMID:
23915195
48.

DNA fragmentation is higher in spermatozoa with chromosomally unbalanced content in men with a structural chromosomal rearrangement.

Perrin A, Nguyen MH, Bujan L, Vialard F, Amice V, Guéganic N, Douet-Guilbert N, De Braekeleer M, Morel F.

Andrology. 2013 Jul;1(4):632-8. doi: 10.1111/j.2047-2927.2013.00100.x.

49.

VEGFR1 and NRP1 endothelial expressions predict distant relapse after radical prostatectomy in clinically localized prostate cancer.

Talagas M, Uguen A, Garlantezec R, Fournier G, Doucet L, Gobin E, Marcorelles P, Volant A, DE Braekeleer M.

Anticancer Res. 2013 May;33(5):2065-75.

PMID:
23645757
50.

The MLL recombinome of acute leukemias in 2013.

Meyer C, Hofmann J, Burmeister T, Gröger D, Park TS, Emerenciano M, Pombo de Oliveira M, Renneville A, Villarese P, Macintyre E, Cavé H, Clappier E, Mass-Malo K, Zuna J, Trka J, De Braekeleer E, De Braekeleer M, Oh SH, Tsaur G, Fechina L, van der Velden VH, van Dongen JJ, Delabesse E, Binato R, Silva ML, Kustanovich A, Aleinikova O, Harris MH, Lund-Aho T, Juvonen V, Heidenreich O, Vormoor J, Choi WW, Jarosova M, Kolenova A, Bueno C, Menendez P, Wehner S, Eckert C, Talmant P, Tondeur S, Lippert E, Launay E, Henry C, Ballerini P, Lapillone H, Callanan MB, Cayuela JM, Herbaux C, Cazzaniga G, Kakadiya PM, Bohlander S, Ahlmann M, Choi JR, Gameiro P, Lee DS, Krauter J, Cornillet-Lefebvre P, Te Kronnie G, Schäfer BW, Kubetzko S, Alonso CN, zur Stadt U, Sutton R, Venn NC, Izraeli S, Trakhtenbrot L, Madsen HO, Archer P, Hancock J, Cerveira N, Teixeira MR, Lo Nigro L, Möricke A, Stanulla M, Schrappe M, Sedék L, Szczepański T, Zwaan CM, Coenen EA, van den Heuvel-Eibrink MM, Strehl S, Dworzak M, Panzer-Grümayer R, Dingermann T, Klingebiel T, Marschalek R.

Leukemia. 2013 Nov;27(11):2165-76. doi: 10.1038/leu.2013.135. Epub 2013 Apr 30.

Supplemental Content

Loading ...
Support Center